← Evidence map

ArticleOncoTargets and therapy2020

Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis.

Shihuan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32753899